Skip to main content

Articles

Page 2 of 2

  1. Kidney transplantation is the best treatment for patients with end-stage renal failure, but uncertainty remains about the best immunosuppression strategy. Long-term graft survival has not improved substantiall...

    Authors: Richard Haynes, Colin Baigent, Paul Harden, Martin Landray, Murat Akyol, Argiris Asderakis, Alex Baxter, Sunil Bhandari, Paramit Chowdhury, Marc Clancy, Jonathan Emberson, Paul Gibbs, Abdul Hammad, Will Herrington, Kathy Jayne, Gareth Jones…
    Citation: Transplantation Research 2013 2:7
  2. Polymorphisms in CYP2C19 are related to the metabolic oxidation of drugs to varying degrees. The CYP3A4*18, CYP3A5*3, and MDR1-3435 variant alleles are very important, particularly in tacrolimus metabolism in org...

    Authors: King-Wah Chiu, Tsung-Hui Hu, Toshiaki Nakano, Kuang-Den Chen, Chia-Yun Lai, Li-Wen Hsu, Hui-Peng Tseng, Ho-Ching Chiu, Yu-Fan Cheng, Shigeru Goto and Chao-Long Chen
    Citation: Transplantation Research 2013 2:6
  3. In the early phases following heart transplantation a main challenge is to reduce the impact of acute rejections. Previous studies indicate that intracellular ciclosporin A (CsA) concentration may be a sensiti...

    Authors: Ida Robertsen, Pål Falck, Arne K Andreassen, Nina K Næss, Niclas Lunder, Hege Christensen, Lars Gullestad and Anders Åsberg
    Citation: Transplantation Research 2013 2:5
  4. Given the unpredictable timing of deceased donor organs and the need for blood transfusion, this study was carried out to determine the rate and risk factors for transfusion in order to identifying a low-risk ...

    Authors: Karim Marzouk, Joseph Lawen and Bryce A Kiberd
    Citation: Transplantation Research 2013 2:4
  5. Critical organ shortage results in the utilization of extended donor criteria (EDC) liver grafts. These marginal liver grafts are prone to increased ischemia reperfusion injury (IRI) which may contribute to de...

    Authors: Sebastian Pratschke, Michael Eder, Michael Heise, Silvio Nadalin, Andreas Pascher, Peter Schemmer, Marcus N Scherer, Frank Ulrich, Heiner Wolters, Karl-Walter Jauch, Dirk Wöhling and Martin K Angele
    Citation: Transplantation Research 2013 2:3
  6. New onset diabetes mellitus (NODM) and acute rejection (AR) are important causes of morbidity and risk factors for allograft failure after kidney transplantation.

    Authors: Edward H Cole, GV Ramesh Prasad, Carl J Cardella, Joseph S Kim, Kathryn J Tinckam, Daniel C Cattran, Jeffrey R Schiff, David N Landsberg, Jeffrey S Zaltzman and John S Gill
    Citation: Transplantation Research 2013 2:1
  7. While immunosuppressive regimens improve the overall survival of renal transplant recipients, they also contribute to the long-term complications of post-transplant malignancies. Chronic immune suppression in ...

    Authors: Oksana Genzer, Suzanne E El-Sayegh, Morton J Kleiner and Mario R Castellanos
    Citation: Transplantation Research 2012 1:21
  8. Organ transplant recipients frequently suffer from toxicity or from lack of efficacy of immunosuppressive drugs, which can be attributed to individual variations in drug sensitivity. This problem can be resolv...

    Authors: Carla Baan, Anne Bouvy, Ramin Vafadari and Willem Weimar
    Citation: Transplantation Research 2012 1:20
  9. Kidneys from donors after cardiac or circulatory death are exposed to extended periods of both warm ischemia and intra-arterial cooling before organ recovery. Marshall’s hypertonic citrate (HOC) and Bretschnei...

    Authors: Colin H Wilson, Hugh Wyrley-Birch, Dhakshinarmoorthy Vijayanand, Anabelle Leea, Noel M Carter, Malcolm Haswell, Anne C Cunningham and David Talbot
    Citation: Transplantation Research 2012 1:18
  10. Several types of myeloid suppressor cell are currently being developed as cell-based immunosuppressive agents. Despite detailed knowledge about the molecular and cellular functions of these cell types, expert ...

    Authors: Paloma Riquelme, Edward K Geissler and James A Hutchinson
    Citation: Transplantation Research 2012 1:17
  11. In efforts to minimize the chronic administration of immunosuppression (IS) drugs in transplantation and autoimmune disease, various cell-based tolerogenic therapies, including the use of regulatory or tolerog...

    Authors: Camila Macedo, Hēth Turquist, Diana Metes and Angus W Thomson
    Citation: Transplantation Research 2012 1:16
  12. Organ transplantation is the main alternative to the loss of vital organ function from various diseases. However, to avoid graft rejection, transplant patients are treated with immunosuppressive drugs that hav...

    Authors: Aurélie Moreau, Emilie Varey, Laurence Bouchet-Delbos and Maria-Cristina Cuturi
    Citation: Transplantation Research 2012 1:13
  13. Mesenchymal stem cells (MSC) mediate their immunosuppressive effects via a variety of mechanisms. One of these mechanisms involves the induction of macrophages with immunomodulatory capacities. This effect of ...

    Authors: Elke Eggenhofer and Martin J Hoogduijn
    Citation: Transplantation Research 2012 1:12
  14. Acute rejection (AR) episodes in renal transplant recipients are suspected when plasma creatinine is elevated and other potential causes out ruled. Graft biopsies are however needed for definite diagnosis. Non...

    Authors: Håvard Loftheim, Karsten Midtvedt, Anders Hartmann, Anna V Reisæter, Pål Falck, Hallvard Holdaas, Trond Jenssen, Leon Reubsaet and Anders Åsberg
    Citation: Transplantation Research 2012 1:9
  15. To improve the welfare of experimental animals, investigators seek to respect the 3R principle (Replacement, Reduction, and Refinement). Even when large animal studies are essential before moving to clinical t...

    Authors: Eiji Kobayashi, Shuji Hishikawa, Takumi Teratani and Alan T Lefor
    Citation: Transplantation Research 2012 1:8
  16. Liver donor shortages stimulate the development of strategies that incorporate damaged organs into the donor pool. Herein we present a simplified machine perfusion system without the need for oxygen carriers o...

    Authors: Tim A Berendsen, Bote G Bruinsma, Jungwoo Lee, Vincent D’Andrea, Qiang Liu, Maria-Louisa Izamis, Korkut Uygun and Martin L Yarmush
    Citation: Transplantation Research 2012 1:6
  17. The use of patients as the primary teaching modality for learning procedures is being questioned. While there have been advancements in the technology used for performing needle biopsies in both native and tra...

    Authors: Kenjiro Konno, Koichi Nakanishi, Shuji Hishikawa, Hozumi Tanaka, Norishige Yoshikawa, Yoshikazu Yasuda, Eiji Kobayashi and Alan Lefor
    Citation: Transplantation Research 2012 1:5
  18. In the direct pathway, T cells recognize intact donor major histocompatability complexes and allogeneic peptide on the surface of donor antigen presenting cells (APCs). Indirect allorecognition results from th...

    Authors: Dmitry Samsonov, Christopher Geehan, Craig B Woda and David M Briscoe
    Citation: Transplantation Research 2012 1:4
  19. We present a review of current strategies for the diagnosis and treatment of coronary artery disease (CAD) in patients with advanced chronic kidney disease who are on the waiting list for transplants, based on...

    Authors: Jose JG De Lima, Luis Henrique W Gowdak and Flavio J de Paula
    Citation: Transplantation Research 2012 1:3
  20. Organs harvested from a body lapsing into circulatory deficit are exposed to low O2/high CO2, and reach a critical point where original functionality after transplantation is unlikely. The present study evaluates...

    Authors: Ippei Yamaoka, Takeshi Kikuchi, Tomohiro Arata and Eiji Kobayashi
    Citation: Transplantation Research 2012 1:2